Evidence map›Paper›PMID 36604186›Full record

ArticleCNS neuroscience & therapeutics2023

Characteristics of the gut microbiota in bipolar depressive disorder patients with distinct weight.

Peifen Zhang, Danhua Zhang, Jianbo Lai, Yaoyang Fu, Lingling Wu, Huimin Huang, Yanmeng Pan, Jiajun Jiang, Caixi Xi, Ziyuan Che and 2 more

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Peifen ZhangDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Danhua ZhangDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jianbo LaiDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-8137-7701
Yaoyang FuDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lingling WuDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Huimin HuangWenzhou Medical University, Wenzhou, China.
Yanmeng PanDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jiajun JiangDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Caixi XiDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ziyuan CheCollege of Agriculture & Biotechnology, Zhejiang University, Hangzhou, China.
Xueqin SongThe First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Shaohua HuDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0003-0570-670X
First Affiliated Hospital Zhejiang University · CNBrain (Germany) · DEFirst Affiliated Hospital of Zhengzhou University · CNWenzhou Medical University · CNZhejiang A & F University · CN

Funding

National Natural Science Foundation of China 81971271the Leading Talent of Scientific and Technological Innovation-'Ten Thousand Talents Programme' of Zhejiang Province 2021R52016the Program from the Health and Family Planning Commission of Zhejiang Province 2020KY548the Zhejiang Provincial Key Research and Development Program 2021C03107the Zhejiang Provincial Natural Science Foundation LQ20H090013
6 · The paper itself

Abstract

backgroundPreliminary studies have indicated metabolic dysfunction and gut dysbiosis in patients with bipolar disorder (BD). In this study, we aimed to clarify the impact of the gut microbial composition and function on metabolic dysfunction in BD patients with an acute depressive episode.

methodsFresh fecal samples were provided from 58 patients with BD depression, including 29 with normal weight (NW) and 29 with overweight/obesity (OW), and 31 healthy controls (HCs). The hypervariable region of 16 S rRNA gene (V3-V4) sequencing was performed using IonS5TMXL platform to evaluate the bacterial communities. Differences of microbial community and correlation to clinical parameters across different groups were analyzed.

resultsCompared to NW and HCs, the OW group showed a decreased tendency in alpha diversity index. Beta diversity was markedly different among these groups (PERMANOVA: R

conclusionsSpecific bacterial taxa involved in pathways regulating the lipid, energy, and amino acid metabolisms may underlie the weight concerns in depressed BD patients. Potential targeting gut microbial therapy is provided for overweight/obesity patients with BD, which still need further studies in the future.

Indexed as

Bipolar DisorderDepressive DisorderGastrointestinal MicrobiomeAmino AcidsHumansLipidsObesityOverweightAmino AcidsLipids16 S rRNAbipolar disordergut microbiotametabolismweight

Identifiers

PMID36604186
PMCPMC10314097
OpenAlexW4313551685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.